Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Stage distribution of screen-detected colorectal cancers in the Netherlands.
Toes-Zoutendijk E, Kooyker AI, Elferink MA, Spaander MCW, Dekker E, Koning HJ, Lemmens VE, van Leerdam ME, Lansdorp-Vogelaar I; LECO working group. Toes-Zoutendijk E, et al. Gut. 2018 Sep;67(9):1745-1746. doi: 10.1136/gutjnl-2017-315111. Epub 2017 Oct 21. Gut. 2018. PMID: 29055907 No abstract available.
Faecal occult blood loss accurately predicts future detection of colorectal cancer. A prognostic model.
Meester RGS, van de Schootbrugge-Vandermeer HJ, Breekveldt ECH, de Jonge L, Toes-Zoutendijk E, Kooyker A, Nieboer D, Ramakers CR, Spaander MCW, van Vuuren AJ, Kuipers EJ, van Kemenade FJ, Nagtegaal ID, Dekker E, van Leerdam ME, Lansdorp-Vogelaar I; Dutch colorectal cancer screening working group. Meester RGS, et al. Gut. 2023 Jan;72(1):101-108. doi: 10.1136/gutjnl-2022-327188. Epub 2022 May 10. Gut. 2023. PMID: 35537811 Free PMC article.
Impact of delayed screening invitations on screen-detected and interval cancers in the Dutch colorectal cancer screening programme: individual-level data analysis.
Toes-Zoutendijk E, de Jonge L, van Iersel CA, Spaander MCW, van Vuuren AJ, van Kemenade F, Ramakers CR, Dekker E, Nagetaal ID, van Leerdam ME, Lansdorp-Vogelaar I. Toes-Zoutendijk E, et al. Gut. 2023 Jul;72(7):1319-1325. doi: 10.1136/gutjnl-2022-328559. Epub 2023 Apr 19. Gut. 2023. PMID: 37076272 Free PMC article.
Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands: a population-based study.
Breekveldt ECH, Lansdorp-Vogelaar I, Toes-Zoutendijk E, Spaander MCW, van Vuuren AJ, van Kemenade FJ, Ramakers CRB, Dekker E, Nagtegaal ID, Krul MF, Kok NFM, Kuhlmann KFD, Vink GR, van Leerdam ME, Elferink MAG; Dutch National Colorectal Cancer Screening Working Group. Breekveldt ECH, et al. Lancet Gastroenterol Hepatol. 2022 Jan;7(1):60-68. doi: 10.1016/S2468-1253(21)00368-X. Epub 2021 Nov 22. Lancet Gastroenterol Hepatol. 2022. PMID: 34822762
Impact of COVID-19 and suspension of colorectal cancer screening on incidence and stage distribution of colorectal cancers in the Netherlands.
Toes-Zoutendijk E, Vink G, Nagtegaal ID, Spaander MCW, Dekker E, van Leerdam ME, Siesling S, Lansdorp-Vogelaar I, Elferink MAG; COVID and Cancer-NL consortium. Toes-Zoutendijk E, et al. Eur J Cancer. 2022 Jan;161:38-43. doi: 10.1016/j.ejca.2021.11.008. Epub 2021 Nov 24. Eur J Cancer. 2022. PMID: 34915408 Free PMC article.
Quality Monitoring of a FIT-Based Colorectal Cancer Screening Program.
Toes-Zoutendijk E, Bonfrer JMG, Ramakers C, Thelen M, Spaander MCW, Dekker E, van der Meulen MP, Buskermolen M, van Vuuren AJ, Kuipers EJ, van Kemenade FJ, van Velthuysen MF, Thomeer MGJ, van Veldhuizen H, van Ballegooijen M, de Koning HJ, van Leerdam ME, Lansdorp-Vogelaar I. Toes-Zoutendijk E, et al. Clin Chem. 2019 Mar;65(3):419-426. doi: 10.1373/clinchem.2018.294041. Epub 2019 Jan 16. Clin Chem. 2019. PMID: 30651228
36 results